Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Besifloxacin vs Vigamox in Bacterial Conjunctivitis
NCT00348348Phase 3Completed
- Sponsor
- Bausch + Lomb
- Start
- Jun 2006
- Primary completion
- Jul 2007
01
Overview
Phase 3, randomised, double-blind trial of Besifloxacin ophthalmic suspension vehicle in bacterial conjunctivitis (BC), sponsored by Bausch + Lomb. Primary endpoints: Clinical Resolution at Day 5 and Microbial Eradication at Day 5. Started Jun 2006; status: completed.
02
Drugs
Besifloxacin ophthalmic suspension vehicle
03
Conditions
bacterial conjunctivitis (BC)
Beyond the preview
Go deeper on NCT00348348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00348348.